75% of Alternative Mutual Funds Have Died. There Are Lessons in That for Would-Be Private Market Investors

Between January 1, 2015 and August 2025, the alternative mutual fund industry experienced a catastrophic contraction, with 75% of liquid alternative funds ceasing operations. Of 1,345 alternative mutual funds in existence at the start of 2015—funds employing hedging, shorting, trend-following, and absolute return strategies—only 341 survived. The remaining 1,004 funds were liquidated or merged away, representing one of the most significant product mortality events in modern asset management.

The failure pattern was not uniform across cohorts. Funds launched further back in time, particularly those originating near the 2008 financial crisis, experienced higher mortality rates than more recent launches. This temporal distribution suggests that alternative strategies faced persistent headwinds across multiple market cycles, indicating structural underperformance rather than isolated cyclical challenges.

The critical issue underlying this failure centers on misaligned sales narratives. During the peak marketing era of liquid alternatives, roughly a decade ago, asset managers promoted these strategies as essential "shock absorbers" to traditional equity-bond portfolios, arguing that rising asset class correlations had rendered conventional diversification ineffective. Fund companies positioned alternatives as a new pathway for retail investors to build more resilient allocations. Yet the actual risk-adjusted returns and downside protection these funds delivered failed to justify their fees or the complexity they introduced to portfolios. As Morningstar's analysis indicates, when sales rhetoric becomes "rhapsodic"—celebrating transformative portfolio benefits—investors should apply heightened scrutiny.

The implications for private markets are direct. As asset managers race to bring fee-rich private equity and private credit strategies to retail and 401(k) audiences, the alternative fund graveyard provides a cautionary template. Private market products carry additional structural risks absent in liquid alternatives: illiquidity, opaque valuations, extended lockup periods, and high fee structures. Regulators are expanding retail access to these vehicles precisely as marketing intensity peaks. The alternative fund experience demonstrates that sophisticated packaging and compelling narratives often precede disappointing outcomes. Institutional investors and advisors should demand rigorous, multi-cycle performance evidence and realistic fee justification before allocating capital to emerging private market strategies targeting mass-market distribution.